Skip to main content
Erschienen in: Surgical Endoscopy 12/2019

27.02.2019 | Affective Disorder

Minor psychiatric disorders and objective diagnosis of gastroesophageal reflux disease

verfasst von: Rafael Melillo Laurino Neto, Fernando A. M. Herbella, Andre Zugman, Vic Velanovich, Beth Montera, Francisco Schlottmann, Marco G. Patti

Erschienen in: Surgical Endoscopy | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Symptoms may be unreliable to diagnose gastroesophageal reflux disease (GERD) in patients with minor psychiatric disorders (MPD). This study aims to evaluate the influence of MPD in the diagnosis of GERD.

Methods

We prospectively studied 245 patients (based on a sample size calculation) with suspected GERD. All patients underwent manometry and pH monitoring and MPD evaluation based on the Hospital Anxiety and Depression Scale (HADS).

Results

Based on the results of the pH monitoring, patients were classified as GERD + (n = 136, 55% of the total, mean age 46 years, 47% females) or GERD − (n = 109, 45% of the total, mean age 43 years, 60% females). The mean HADS score for GERD + and GERD − for anxiety was 7.8 and 8.5, respectively (p = 0.8) and for depression was 5.4 and 6.1, respectively (p = 0.1). DeMeester score (DS) did not correlate with total HADS score (p = 0.08) or depression domain (p = 0.9) but there was a negative correlation between DS and anxiety level (p < 0.001). A significant threshold accuracy value for HADS to diagnose GERD was not found on receiver operating characteristics curve analysis.

Conclusion

Almost half of the patients evaluated for GERD did not have the disease on objective evaluation. GERD + and GERD − patients had similar levels of MPD. However, the amount of reflux correlated negatively with the severity of anxiety. Symptoms and HADS cannot accurately diagnose or exclude GERD. pH monitoring should be more liberally used especially in patients with high levels of anxiety.
Literatur
1.
Zurück zum Zitat Vakil N et al (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101(8):1900–1920. (quiz 1943)CrossRef Vakil N et al (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101(8):1900–1920. (quiz 1943)CrossRef
2.
Zurück zum Zitat El-Serag HB et al (2014) Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 63(6):871–880CrossRef El-Serag HB et al (2014) Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 63(6):871–880CrossRef
3.
Zurück zum Zitat Dent J et al (2010) Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut 59(6):714–721CrossRef Dent J et al (2010) Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut 59(6):714–721CrossRef
4.
Zurück zum Zitat Nasi A et al (2001) Gastroesophageal reflux disease: comparison between patients with and without esophagitis, concerning age, gender and symptoms. Arq Gastroenterol 38(2):109–115CrossRef Nasi A et al (2001) Gastroesophageal reflux disease: comparison between patients with and without esophagitis, concerning age, gender and symptoms. Arq Gastroenterol 38(2):109–115CrossRef
5.
Zurück zum Zitat Moraes-Filho JP et al (2010) Guidelines for the diagnosis and management of gastroesophageal reflux disease: an evidence-based consensus. Arq Gastroenterol 47(1):99–115CrossRef Moraes-Filho JP et al (2010) Guidelines for the diagnosis and management of gastroesophageal reflux disease: an evidence-based consensus. Arq Gastroenterol 47(1):99–115CrossRef
6.
Zurück zum Zitat Andolfi C et al (2016) Importance of esophageal manometry and pH monitoring in the evaluation of patients with refractory gastroesophageal reflux disease: a multicenter study. J Laparoendosc Adv Surg Tech A 26(7):548–550CrossRef Andolfi C et al (2016) Importance of esophageal manometry and pH monitoring in the evaluation of patients with refractory gastroesophageal reflux disease: a multicenter study. J Laparoendosc Adv Surg Tech A 26(7):548–550CrossRef
7.
Zurück zum Zitat Olden KW (2008) Psychosocial factors in functional gastrointestinal disorders: an evolving phenomenon. Neurogastroenterol Motil 20(Suppl 1):114–120CrossRef Olden KW (2008) Psychosocial factors in functional gastrointestinal disorders: an evolving phenomenon. Neurogastroenterol Motil 20(Suppl 1):114–120CrossRef
9.
Zurück zum Zitat Nunez-Rodriguez MH, Miranda A, Sivelo (2008) Psychological factors in gastroesophageal reflux disease measured by scl-90-R questionnaire. Dig Dis Sci 53(12):3071–3075CrossRef Nunez-Rodriguez MH, Miranda A, Sivelo (2008) Psychological factors in gastroesophageal reflux disease measured by scl-90-R questionnaire. Dig Dis Sci 53(12):3071–3075CrossRef
10.
Zurück zum Zitat Lee KJ et al (2009) Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group. Digestion 79(3):131–136CrossRef Lee KJ et al (2009) Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group. Digestion 79(3):131–136CrossRef
11.
Zurück zum Zitat Wiklund I et al (2006) Psychological factors as a predictor of treatment response in patients with heartburn: a pooled analysis of clinical trials. Scand J Gastroenterol 41(3):288–293CrossRef Wiklund I et al (2006) Psychological factors as a predictor of treatment response in patients with heartburn: a pooled analysis of clinical trials. Scand J Gastroenterol 41(3):288–293CrossRef
12.
Zurück zum Zitat Velanovich V, Karmy-Jones R (2001) Psychiatric disorders affect outcomes of antireflux operations for gastroesophageal reflux disease. Surg Endosc 15(2):171–175CrossRef Velanovich V, Karmy-Jones R (2001) Psychiatric disorders affect outcomes of antireflux operations for gastroesophageal reflux disease. Surg Endosc 15(2):171–175CrossRef
13.
Zurück zum Zitat Del Grande LM, Herbella FA, Bigatao AM, Abrao H, Jardim JR, Patti MG (2016) Pathophysiology of gastroesophageal reflux in patients with chronic pulmonary obstructive disease is linked to an increased transdiaphragmatic pressure gradient and not to a defective esophagogastric barrier. J Gastrointest Surg 20(1):104–110CrossRef Del Grande LM, Herbella FA, Bigatao AM, Abrao H, Jardim JR, Patti MG (2016) Pathophysiology of gastroesophageal reflux in patients with chronic pulmonary obstructive disease is linked to an increased transdiaphragmatic pressure gradient and not to a defective esophagogastric barrier. J Gastrointest Surg 20(1):104–110CrossRef
14.
Zurück zum Zitat DeMeester TR et al (1980) Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg 79(5):656–670PubMed DeMeester TR et al (1980) Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg 79(5):656–670PubMed
15.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRef Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRef
16.
Zurück zum Zitat Andrade LH et al (2012) Mental disorders in megacities: findings from the Sao Paulo megacity mental health survey, Brazil. PLoS ONE 7(2):e31879CrossRef Andrade LH et al (2012) Mental disorders in megacities: findings from the Sao Paulo megacity mental health survey, Brazil. PLoS ONE 7(2):e31879CrossRef
17.
Zurück zum Zitat Avidan B et al (2001) Reflux symptoms are associated with psychiatric disease. Aliment Pharmacol Ther 15(12):1907–1912CrossRef Avidan B et al (2001) Reflux symptoms are associated with psychiatric disease. Aliment Pharmacol Ther 15(12):1907–1912CrossRef
18.
Zurück zum Zitat Martin-Merino E et al (2010) Depression and treatment with antidepressants are associated with the development of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 31(10):1132–1140PubMed Martin-Merino E et al (2010) Depression and treatment with antidepressants are associated with the development of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 31(10):1132–1140PubMed
19.
Zurück zum Zitat Hartono JL, Mahadeva S, Goh KL (2012) Anxiety and depression in various functional gastrointestinal disorders: do differences exist? J Dig Dis 13(5):252–257CrossRef Hartono JL, Mahadeva S, Goh KL (2012) Anxiety and depression in various functional gastrointestinal disorders: do differences exist? J Dig Dis 13(5):252–257CrossRef
20.
Zurück zum Zitat Jansson C et al (2007) Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment Pharmacol Ther 26(5):683–691CrossRef Jansson C et al (2007) Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment Pharmacol Ther 26(5):683–691CrossRef
21.
Zurück zum Zitat Baker LH, Lieberman D, Oehlke M (1995) Psychological distress in patients with gastroesophageal reflux disease. Am J Gastroenterol 90(10):1797–1803PubMed Baker LH, Lieberman D, Oehlke M (1995) Psychological distress in patients with gastroesophageal reflux disease. Am J Gastroenterol 90(10):1797–1803PubMed
22.
Zurück zum Zitat Mykletun A et al (2010) Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women. BMC Gastroenterol 10:88CrossRef Mykletun A et al (2010) Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women. BMC Gastroenterol 10:88CrossRef
23.
Zurück zum Zitat Kessing BF et al (2015) Effects of anxiety and depression in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 13(6):1089–195.e1CrossRef Kessing BF et al (2015) Effects of anxiety and depression in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 13(6):1089–195.e1CrossRef
24.
Zurück zum Zitat Neto SC et al (2014) Ratio between proximal/distal gastroesophageal reflux does not discriminate abnormal proximal reflux. World J Surg 38(4):890–896CrossRef Neto SC et al (2014) Ratio between proximal/distal gastroesophageal reflux does not discriminate abnormal proximal reflux. World J Surg 38(4):890–896CrossRef
25.
Zurück zum Zitat Oh JH et al (2009) Relationship between psychological factors and quality of life in subtypes of gastroesophageal reflux disease. Gut Liver 3(4):259–265CrossRef Oh JH et al (2009) Relationship between psychological factors and quality of life in subtypes of gastroesophageal reflux disease. Gut Liver 3(4):259–265CrossRef
26.
Zurück zum Zitat O’Boyle CJ et al (2002) Preoperative prediction of long-term outcome following laparoscopic fundoplication. ANZ J Surg 72(7):471–475CrossRef O’Boyle CJ et al (2002) Preoperative prediction of long-term outcome following laparoscopic fundoplication. ANZ J Surg 72(7):471–475CrossRef
27.
Zurück zum Zitat Taft TH et al (2018) Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease. Aliment Pharmacol Ther 47(9):1270–1277CrossRef Taft TH et al (2018) Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease. Aliment Pharmacol Ther 47(9):1270–1277CrossRef
28.
Zurück zum Zitat Boltin D et al (2013) Psychological distress is not associated with treatment failure in patients with gastroesophageal reflux disease. J Psychosom Res 75(5):462–466CrossRef Boltin D et al (2013) Psychological distress is not associated with treatment failure in patients with gastroesophageal reflux disease. J Psychosom Res 75(5):462–466CrossRef
29.
Zurück zum Zitat Yang XJ et al (2015) Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life. World J Gastroenterol 21(14):4302–4309CrossRef Yang XJ et al (2015) Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life. World J Gastroenterol 21(14):4302–4309CrossRef
30.
Zurück zum Zitat Kimura Y et al (2016) Persistent reflux symptoms cause anxiety, depression, and mental health and sleep disorders in gastroesophageal reflux disease patients. J Clin Biochem Nutr 59(1):71–77CrossRef Kimura Y et al (2016) Persistent reflux symptoms cause anxiety, depression, and mental health and sleep disorders in gastroesophageal reflux disease patients. J Clin Biochem Nutr 59(1):71–77CrossRef
31.
Zurück zum Zitat Bilgi MM et al (2017) Prevalence of psychiatric comorbidity in symptomatic gastroesophageal reflux subgroups. Dig Dis Sci 62(4):984–993CrossRef Bilgi MM et al (2017) Prevalence of psychiatric comorbidity in symptomatic gastroesophageal reflux subgroups. Dig Dis Sci 62(4):984–993CrossRef
32.
Zurück zum Zitat Okuyama M et al (2017) Associations among gastroesophageal reflux disease, psychological stress, and sleep disturbances in Japanese adults. Scand J Gastroenterol 52(1):44–49CrossRef Okuyama M et al (2017) Associations among gastroesophageal reflux disease, psychological stress, and sleep disturbances in Japanese adults. Scand J Gastroenterol 52(1):44–49CrossRef
33.
Zurück zum Zitat Javadi S, Shafikhani AA (2017) Anxiety and depression in patients with gastroesophageal reflux disorder. Electron Physician 9(8):5107–5112CrossRef Javadi S, Shafikhani AA (2017) Anxiety and depression in patients with gastroesophageal reflux disorder. Electron Physician 9(8):5107–5112CrossRef
Metadaten
Titel
Minor psychiatric disorders and objective diagnosis of gastroesophageal reflux disease
verfasst von
Rafael Melillo Laurino Neto
Fernando A. M. Herbella
Andre Zugman
Vic Velanovich
Beth Montera
Francisco Schlottmann
Marco G. Patti
Publikationsdatum
27.02.2019
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 12/2019
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-019-06716-y

Weitere Artikel der Ausgabe 12/2019

Surgical Endoscopy 12/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.